vidarabine has been researched along with Leukemia L5178 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arendes, J; Geurtsen, W; Maidhof, A; Müller, WE; Zahn, RK | 1 |
| Kapiszewska, M; Lange, CS | 1 |
2 other study(ies) available for vidarabine and Leukemia L5178
| Article | Year |
|---|---|
Metabolism of 9-beta-D-arabinofuranosylhypoxanthine and 9-beta-D-arabinofuranosyladenine in L5178y mouse lymphoma cells.
Topics: Animals; Arabinonucleosides; Cells, Cultured; DNA-Directed DNA Polymerase; Hypoxanthines; Leukemia L5178; Leukemia, Experimental; Mice; Neoplasm Proteins; Nucleic Acids; Vidarabine | 1981 |
Effect of inhibition of DNA synthesis on recovery of X-irradiated L5178Y-S cells, II. 9-beta-D-arabinofuranosyladenine.
Topics: Animals; Cell Survival; DNA Damage; DNA Repair; DNA Replication; DNA, Neoplasm; Leukemia L5178; Mice; Radiation Tolerance; Time Factors; Tumor Cells, Cultured; Vidarabine | 1989 |